Alkindi: payments to doctors
Payments that named Alkindi as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $337K
- Providers
- 603
- Transactions
- 1,140
- Average per transaction
- $296
The per-transaction average — $296 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 603 providers the average total is $559, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Eton Pharmaceuticals, Inc. | $334,189 | 99.1% |
| Tolmar Pharmaceuticals, Inc. | $2,958 | 0.9% |